
The FDA Just Approved a Monthly Olanzapine Shot With No Observation Period — and the Post-Injection Delirium Warning Stayed on the Label — Here’s What Every PMHNP Student Needs to Know
The FDA approved Weltruza, the first once-monthly subcutaneous olanzapine, on October 9, 2026. Here is what PMHNP students need to…